Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study
Salarius subsidiary Decoy Therapeutics’ influenza fusion inhibitors, designed using its proprietary IMP3ACT™ platform, show ...
kcra.com
FDA official plans to change vaccine approval process
A senior Food and Drug Administration official on Friday said the agency will change its vaccine approval process, alleging that COVID-19 vaccination resulted in the deaths of 10 children.Video above: ...
CNN
FDA official plans to change vaccine approval process, claiming that Covid-19 shots caused child deaths
A senior Food and Drug Administration official on Friday said the agency will change its vaccine approval process, alleging that Covid-19 vaccination resulted in the deaths of 10 children. In an ...
The Hill
FDA to tighten vaccine rules after memo ties COVID-19 shot to child deaths
The Food and Drug Administration (FDA) is set to implement stricter vaccine approval guidelines after a memo claimed at least 10 children died “after and because of” receiving a COVID-19 shot. The ...
The Washington Post
Blaming some child deaths on covid shots, FDA vows stricter vaccine rules
The nation’s top vaccine regulator on Friday laid out a stricter approach for federal vaccine approvals, citing his team’s conclusion, without detailing the evidence, that coronavirus vaccines had ...
The American Journal of Managed Care
FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy
Sibeprenlimab is approved for IgAN treatment, showing a 51.2% reduction in proteinuria in the VISIONARY trial. Administered subcutaneously every four weeks, it inhibits APRIL to reduce IgA levels.
Newsday
Some COVID-19 at-home tests can be used beyond expiration date on box. Find out which ones.
As folks travel to see loved ones for the holiday season, there’s one thing no one wants to pack — an infectious disease. But whether you have the sniffles or just want to take precautions around ...
STAT
FDA approves Otsuka kidney disease therapy
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
The Harvard Crimson
FDA Approves New Drug for Treating Most Common Type of Lung Cancer, Based on Broad Institute Research
FDA Approves New Drug for Treating Most Common Type of Lung Cancer, Based on Broad Institute Research The Broad Institute, a research collaboration between Harvard and MIT, is a center for biomedical ...